Capex WireMore than $126 billion in U.S. capital projects on the map, with new ones every day. Just $9.90/month, cancel anytime.Subscribe ›
Thursday, Nov. 19, 2026 · U.S. editionNov. 19, 2026How we reportLog inSubscribe to Capex Wire

U.S. capital projects before the bid list closes.

Healthcare & Life Sciences · NC

Bracco Imaging to build $230 million sterile contrast media plant in Sanford, North Carolina.

The Italian company's first U.S. manufacturing site would create 200 jobs in Lee County. No construction schedule has been given.

Quick answer

Bracco Imaging: $230 million investment in Sanford, N.C. Stage: Announced. Timeline: Announced Oct. 27, 2026. Construction start and opening not disclosed. Fully staffed by 2031, per the Sanford Area Growth Alliance. Likely to buy: cleanroom construction, process piping, hvac and controls, electrical.

Row of sealed glass vials on a laboratory tray
Illustrative photo. Photo: Jess Loiterton / Pexels

By Capex Wire StaffPublished 2 min read

Bracco Imaging will invest $230 million to build a sterile manufacturing plant for injectable contrast media in Sanford, North Carolina, the company's first manufacturing site in the United States, Gov. Josh Stein announced Oct. 27.

The project will create 200 jobs in Lee County, including manufacturing, engineering and technical roles along with quality, warehousing and administrative positions, according to the North Carolina Department of Commerce.

Bracco, founded in 1927 and based in Milan, Italy, is a family-owned diagnostic imaging company with production plants in Europe, Asia and Canada. The United States is its largest market, MedTech Dive reported.

What the plant will make

The Sanford plant will produce injectable contrast media, the agents used to improve images in medical scans. MedTech Dive reported that the products include non-iodinated agents for MRI, among them Vueway and ProHance, and iodinated products for CT imaging.

The company says local production will expand capacity and make supply to U.S. hospitals more resilient. Supply of iodinated contrast media in the United States was disrupted in 2022 after a COVID-19 lockdown halted production at a GE HealthCare plant in Shanghai, MedTech Dive noted.

"As a family-owned company, we invest for the long term," said Fulvio Renoldi Bracco, vice chairman and chief executive of Bracco Imaging.

Capex Wire

Get there first: every project owner on the U.S. Project Map.

Hundreds of projects have not broken ground yet. See who is building each one, with address, design firm and source, before the bid list closes.

more than $126 billion

in announced or filed value

Subscribe for $9.90/month

Cancel anytime in one click.

Incentives

The state's Economic Investment Committee approved a Job Development Investment Grant for Bracco Imaging Operations USA LLC on Oct. 27. The grant could reimburse the company up to $2,859,300 over 12 years, paid only after the state verifies each year that job and investment targets were met.

State officials estimate an annual payroll impact of more than $20.6 million for the region.

Partners on the project include the Economic Development Partnership of North Carolina, the North Carolina Biotechnology Center, Central Carolina Community College, Lee County, the city of Sanford, the Sanford Area Growth Alliance and Duke Energy.

What is not disclosed

The announcement does not give a construction start, an opening date, the size of the building or the address of the site. No general contractor, architect or process engineering firm has been named. The Sanford Area Growth Alliance says the plant should be fully staffed by 2031, according to MedTech Dive, which is the only schedule marker made public. Local incentives from Lee County and the city of Sanford, if any, were not detailed.

Project fileNC
Owner
Bracco Imaging
Investment
$230 million ($230 million, per state announcement)
Location
Sanford, Lee County, North Carolina
Type
Sterile injectable manufacturing plant, new construction
Stage
Announced
Timeline
Announced Oct. 27, 2026. Construction start and opening not disclosed. Fully staffed by 2031, per the Sanford Area Growth Alliance.
Contractor / EPC
Not announced
Sources
North Carolina Department of Commerce, MedTech Dive

Why it matters

Sterile injectable plants are heavy on cleanrooms, process piping and validated utilities, which is specialized and high-value work. No builder has been named, so the time to get on bid lists is now.

What this project buys

  • Cleanroom construction
  • Process piping
  • HVAC and controls
  • Electrical
  • Process equipment installation
  • Concrete and structural steel

When to approach: Not disclosed. No construction start or builder announced. Staffing target of 2031 suggests design and bidding in 2027.

Typical scopes for a project of this type. This is an editorial estimate, not a list of awarded or advertised packages.

Sources

More capital projects